Preliminary Program subject to change
Ion Channel
Presentation Type	Oral
Summary Statement
Presider:	Thomas J. Caufield, Sanofi-Aventis, Bridgewater, NJ
Introductory Remarks Thomas Caulfield Blocking Ion Channel KCNN4 Alleviates the Symptoms of Experimental Autoimmune Encephalomyelitis in Mice Chuan-Chu Chou, Eva-Pia Reich, Long Cui, Lily Yang, Catherine Pugliese-Sivo, Andrei Golovko, Mary Petro, Galya Vassileva, Inhou Chu, Amin A. Nomeir, Li-Kang Zhang, Xian Liang, Joseph A. Kozlowski, Satwant K. Narula and Paul J. Zavodny, Schering-Plough Research Institute, Kenilworth, NJ Ion Channel Modulation: Can it Enhance Neurotransmission, Conduction, and Myelination for New Therapeutic Interventions? Craig P. Smith, Sanofi-Aventis, Bridgewater, NJ Coffee Break De novo design of potent T-type calcium channel blockers Daniel L. Cheney, Jon Hangeland, Todd Friends and Paul Levesque, Bristol-Meyers Squibb PRI, Hopewell, NJ Identification of Ion Channel Modulators Maria L. Garcia, Merck Research Laboratories, Rahway, NJ

General Submissions